GlassScriptPhysician profile
Chirag Kirit Desai
NPI 1922435932
$1,723.94
in general payments reported to CMS, 2019-2025
18 companies · $46.88 in 2025
The $46.88 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $95.21 · 2021: $406 · 2022: $604 · 2023: $297 · 2024: $144 · 2025: $46.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $488.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $404.82 | 2021-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $221.13 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $174.81 | 2022-2024 | Verquvo |
| Amgen INC. | $153.71 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $142.33 | 2020-2023 | Xarelto |
| Abiomed | $115.86 | 2022 | |
| Amarin Pharma, INC. | $100.68 | 2019-2021 | |
| Edwards Lifesciences Corporation | $68.20 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novo Nordisk INC | $64.69 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $58.51 | 2022-2023 | Eliquis |
| Kiniksa Pharmaceuticals International, Plc | $42.08 | 2024 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.83 | 2019-2024 | Lifevest |
| Kowa Pharmaceuticals America, INC. | $33.06 | 2020-2023 | Livalo |
| Astrazeneca Pharmaceuticals LP | $29.04 | 2019-2022 | |
| Scpharmaceuticals INC. | $25.23 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $21.18 | 2021 | |
| Arbor Pharmaceuticals, INC. | $15.96 | 2021 | |
| Preventice Services, LLC | $14.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chirag Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.